live cell imaging dishes (Eppendorf AG)
Eppendorf AG is a verified supplier 
99
Structured Review
Eppendorf AG
live cell imaging dishes
Live Cell Imaging Dishes, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 99/100, based on 205264 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/live+cell+imaging+dishes/Eppendorf/pm40123001-457-17-20
Average 99 stars, based on 205264 article reviews
Live Cell Imaging Dishes, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 99/100, based on 205264 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/live+cell+imaging+dishes/Eppendorf/pm40123001-457-17-20
Average 99 stars, based on 205264 article reviews
live cell imaging dishes - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Multiple Displacement Amplification:Article Title: Genome-wide CRISPR activation screen identifies ARL11 as a sensitivity determinant of PARP inhibitor therapy. Article Snippet: Resistance to poly-(ADP)-ribose polymerase inhibitors (PARPi) remains a significant challenge in clinical practice, leading to treatment failure in many patients.. It is crucial to better understand the molecular mechanisms that underlie PARPi resistance.. In this study, utilizing a genome-wide CRISPR activation screen with olaparib, we identified ARL11 as a potential modulator of PARPi treatment response in BRCA-wild-type MDA-MB-231 cells. Live Cell Imaging:Article Title: Genome-wide CRISPR activation screen identifies ARL11 as a sensitivity determinant of PARP inhibitor therapy. Article Snippet: Resistance to poly-(ADP)-ribose polymerase inhibitors (PARPi) remains a significant challenge in clinical practice, leading to treatment failure in many patients.. It is crucial to better understand the molecular mechanisms that underlie PARPi resistance.. In this study, utilizing a genome-wide CRISPR activation screen with olaparib, we identified ARL11 as a potential modulator of PARPi treatment response in BRCA-wild-type MDA-MB-231 cells. Article Title: ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling Article Snippet: The cells were imaged under a confocal microscope, and nuclear and cytoplasmic fluorescence intensities of ARL11-GFP were determined using ImageJ software (National Institutes of Health) and plotted as a ratio. .. For FRAP experiments, HeLa cells were seeded into 35-mm Transfection:Article Title: ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling Article Snippet: The cells were imaged under a confocal microscope, and nuclear and cytoplasmic fluorescence intensities of ARL11-GFP were determined using ImageJ software (National Institutes of Health) and plotted as a ratio. .. For FRAP experiments, HeLa cells were seeded into 35-mm Plasmid Preparation:Article Title: ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling Article Snippet: The cells were imaged under a confocal microscope, and nuclear and cytoplasmic fluorescence intensities of ARL11-GFP were determined using ImageJ software (National Institutes of Health) and plotted as a ratio. .. For FRAP experiments, HeLa cells were seeded into 35-mm Fluorescence:Article Title: Genome-wide CRISPR activation screen identifies ARL11 as a sensitivity determinant of PARP inhibitor therapy. Article Snippet: Resistance to poly-(ADP)-ribose polymerase inhibitors (PARPi) remains a significant challenge in clinical practice, leading to treatment failure in many patients.. It is crucial to better understand the molecular mechanisms that underlie PARPi resistance.. In this study, utilizing a genome-wide CRISPR activation screen with olaparib, we identified ARL11 as a potential modulator of PARPi treatment response in BRCA-wild-type MDA-MB-231 cells. |